Postmarket Requirements and Commitments
Postmarket requirement and commitment studies and clinical trials occur after a drug or biological product has been approved by FDA. For more information, please read: "Report to Congress: Reports on Postmarketing Studies [FDAMA 130]" and the Guidance for Industry (PDF - 456KB). A separate Web site is available for post approval studies for medical devices.
FDA Home | Drugs Home | Vaccines, Blood & Biologics Home
For technical questions about the quarterly updates to the PMR/PMC Searchable Database and Downloadable File: pmcweb@fda.hhs.gov